Familial Lewy body diseases

Journal of Geriatric Psychiatry and Neurology

Volumn 15, Issue 4, 2002, Pages 217-223

  Gwinn Hardy, Katrina ^a   Singleton, Amanda Adam ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN;

DEMENTIA; FAMILIAL DISEASE; GENE LOCUS; GENE MUTATION; GENETIC RISK; HUMAN; LEWY BODY; NEUROLOGIC DISEASE; PARKINSONISM; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

EID: 0036896577     PISSN: 08919887     EISSN: None     Source Type: Journal    
DOI: 10.1177/089198870201500407     Document Type: Review

References (76)

1. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB International Workshop. Neurology 1996; 47:1113-1124.
2. McKeith I, Fairbairn A, Perry R, et al. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ 1992; 19:305:673-678.
3. Samuel W, Caligiuri M, Galasko D, et al. Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: A preliminary study. Int J Geriatr Psychiatry 2000; 15:794-802.
4. Boeve BF, Silber MH, Ferman TJ, et al. REM sleep behavior disorder and degenerative dementia: An association likely reflecting Lewy body disease. Neurology 1998; 51:363-367.
5. Dickson DW. Alpha-synuclein and the Lewy body disorders. Curr Opin Neurol 2001; 14:423-432
6. Katzman R, Galasko D, Saitoh T, et al. Genetic evidence that the Lewy body variant is indeed a phenotypic variant of Alzheimer's disease. Brain Cogn 1995; 28:259-265.
7. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997; 276:2045-2047.
8. Spillantini MG, Schmidt ML, Lee VM, et al. Alpha-synuclein in Lewy bodies. Nature 1997; 28:388:839-840.
9. Dickson DW, Liu W-K, Hardy J, et al. Glial cytoplasmic inclusions (GCI) of multiple system atrophy (MSA) contain alphasynuclein. Mov Disord 1998; 13(Suppl12):128.
10. Wakabayashi K, Yoshimoto M, Tsuji S, Takahashi H. Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett 1998; 249:180-182.
11. Lippa CF, Schmidt ML, Lee VM-Y, Trojanowski JQ. Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease. Ann Neurol 1999; 45:353-357.
12. Arawaka S, Saito Y, Murayama S, Mori H. Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein. Neurology 1998; 51:887-889.
13. Wakabayashi K, Fukushima T, Koide R, et al. Juvenile-onset generalized neuroaxonal dystrophy (Hallervorden-Spatz disease) with diffuse neurofibrillary and Lewy body pathology. Acta Neuropathol (Berl) 2000; 99:331-336.
14. Lowe J, Mayer RJ, Landon M. Ubiquitin in neurodegenerative diseases. Brain Pathol 1993; 3:55-65.
15. Bugiani O, Giaccone G, Piccardo P, et al. Neuropathology of Gerstmann-Straussler-Scheinker disease. Microsc Res Tech 2000; 50(1):10-15.
16. Lippa CF, Fujiwara H, Mann DMA, et al. Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol 1998; 153:1365-1370.
17. Dickson DW, Farrer MJ, Mehta ND, et al. Antibodies to nonamyloid component of plaques (NACP) specifically label Lewy bodies and Lewy neurites, but not other inclusions in neurodegenerative diseases. J Neuropathol Exp Neurol 1998; 57:516.
18. Galvin JE, Lee VM, Trojanowski JQ. Synucleinopathies: Clinical and pathological implications. Arch Neurol 2001; 58:186-190.
19. Farrer M, Gwinn-Hardy K, Hutton M, Hardy J. The genetics of disorders with synuclein pathology and parkinsonism. Hum Mol Genet 1999; 8:1901-1905.
20. Golbe LI, Di Iorio G, Sanges G, et al. Clinical genetic analysis of Parkinson's disease in the Contursi kindred. Ann Neurol 1998; 40:767-775.
21. Polymeropoulos MH, Higgins JJ, Golbe LI, et al. Mapping of a gene for Parkinson's disease to chromosome 4q21-q23. Science 1996; 15:274:1197-1199.
22. Krüger R, Kuhn W, Muller T, et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 1998; 18:106-108.
23. Langston JW, Sastry S, Chan P, et al. Novel alpha-synuclein-immunoreactive proteins in brain samples from the Contursi kindred, Parkinson's, and Alzheimer's disease. Exp Neurol 1998; 154:684-690.
24. Clayton DF, George JM. The synucleins: A family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci 1998; 21:249-254.
25. Masliah E, Rockenstein E, Veinbergs I, et al. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: Implications for neurodegenerative disorders. Science 2000; 18:287:1265-1269.
26. Matsuoka Y, Vila M, Lincoln S, et al. Lack of nigral pathology in transgenic mice expressing human α-synuclein driven by the tyrosine hydroxylase promoter. Neurobiol Dis 2000; 8:535-539.
27. Abeliovich A, Schmitz Y, Farinas I, et al. Mice lacking alphasynuclein display functional deficits in the nigrostriatal dopamine system. Neuron 2000; 25:239-252.
28. Feany MB, Bender WW. A Drosophila model of Parkinson's disease. Nature 2000; 23:404:394-398.
29. Vaughan J, Farrer M, Gasser T, et al, and The European Consortium on Genetic Susceptibility in Parkinson's Disease (GSPD). Sequencing of the a-synuclein gene in 27 kindreds with familial Parkinson's disease. Hum Mol Genet 1998; 7:751-753.
30. Spellman GG. Report of familial cases of Parkinsonism. Evidence of a dominant trait in a patient's family. JAMA 1962; 179:160-162.
31. Muenter MD, Forno LS, Hornykiewicz O, et al. Hereditary form of parkinsonism - Dementia. Ann Neurol 1998; 43:768-781.
32. Gwinn-Hardy K, Mehta ND, Farrer M, et al. Distinctive neuropathology revealed by α-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p. Acta Neuropathol (Berl) 2000; 99:663-672.
33. Waters CH, Miller CA. Autosomal dominant parkinsonism in a four generation family. Ann Neurol 1994; 35:59-64.
34. Farrer M, Gwinn-Hardy K, Muenter M, et al. A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor. Hum Mol Genet 1999; 8:81-85.
35. Denson MA, Wszolek ZK, Pfeiffer RF, et al. Familial parkinsonism, dementia, and Lewy body disease: Study of family G. Ann Neurol 1997; 42:638-643.
36. Wakabayashi K, Hayashi S, Ishikawa A, et al. Autosomal dominant diffuse Lewy body disease. Acta Neuropathol (Berl) 1998; 96:207-210.
37. Wakabayashi K, Takahashi H. Gallyas-positive, tau-negative glial inclusions in Parkinson's disease midbrain. Neurosci Lett 1996; 217:133-136.
38. Ishikawa A, Takahashi H, Tanaka H, et al. Clinical features of familial diffuse Lewy body disease. Eur Neurol 1997; 38(Suppl 1):34-38.
39. Ohara K, Takauchi S, Kokai M, et al. Familial dementia with Lewy bodies (DLB). Clin Neuropathol 1999; 18:232-239.
40. Golbe LI, Lazzarini AM, Schwarz KO, et al. Autosomal dominant parkinsonism with benign course and typical Lewy-body pathology. Neurology 1993; 43:222-227.
41. Wszolek ZK, Cordes M, Calne DB, et al. Hereditary Parkinson disease: Report of 3 families with dominant autosomal inheritance. Nervenarzt 1993; 64:331-335.
42. Wszolek ZK, Gwinn-Hardy K, Muenter D, et al. Neuropathology of two members of a German-American kindred (family C) with late onset parkinsonism. Acta Neuropathol (Berl) 2002; 103:334-50
43. Chinnery PF, Taylor GA, Howell N, et al. Mitochondrial DNA haplogroups and susceptibility to AD and dementia with Lewy bodies. Neurology 2000; 55:302-304.
44. Galasko D, Saitoh T, Xia Y, et al. The apolipoprotein E allele epsilon 4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease. Neurology 1994; 44:1950-1951.
45. Armstrong M, Daly AK, Cholerton S, et al. Mutant debrisoquine hydroxylation genes in Parkinson's disease. Lancet 1992; 339:1017-1018.
46. Smith CA, Gough AC, Leigh PN, et al. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet 1992; 339:1375-1377.
47. Bordet R, Broly F, Destee A, Libersa C. Genetic polymorphism of cytochrome P450 2D6 in idiopathic Parkinson disease and diffuse Lewy body disease. Clin Neuropharmacol 1994; 17:484-488.
48. Xu W, Liu L, Emson P, et al. The CCTTT polymorphism in the NOS2A gene is associated with dementia with Lewy bodies. Neuroreport 2000; 11:297-299.
49. Singleton AB, Gibson AM, McKeith IG, et al. Nitric oxide synthase gene polymorphisms in Alzheimer's disease and dementia with Lewy bodies. Neurosci Lett 2001; 303:33-36.
50. Trojanowski JQ, Lee VM. Parkinson's disease and related neurodegenerative synucleinopathies linked to progressive accumulations of synuclein aggregates in brain. Parkinsonism Relat Disord 2001; 7:247-251.
51. Baba M, Nakajo S, Tu PH, et al. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 1998; 152:879-884.
52. Farrer M, Gwinn-Hardy K, Hutton M, Hardy J. The genetics of disorders with synuclein pathology and parkinsonism. Hum Mol Genet 1999; 8:1901-1905.
53. Hardy J, Gwinn-Hardy K. Neurodegenerative disease: A different view of diagnosis. Mol Med Today 1999; 5:514-517.
54. Leroy E, Boyer R, Auburger G. The ubiquitin pathway in Parkinson's disease. Nature 1998; 395:451-452.
55. Hardy J. Pathways to primary neurodegenerative disease. Ann N Y Acad Sci 2000; 924:29-34.
56. Kruger R, Kuhn W, Leenders KL, et al. Familial parkinsonism with synuclein pathology: Clinical and PET studies of A30P mutation carriers. Neurology 2001;56:1355-1362.
57. Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998; 392:605-608.
58. Gasser T, Muller-Myhsok B, Wszolek ZK, et al. A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nat Genet 1998; 18:262-265.
59. Goate AM, Chartier-Harlin MC, Mullan M, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991; 349:704-706.
60. Sherrington R, Rogaev EI, Liang Y, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995; 375:754-760.
61. Levy-Lahad E, Wasco W, Poorkaj P, et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995; 269:973-977.
62. Hansen LA, Samuel W. Criteria for Alzheimer's disease and the nosology of dementia with Lewy bodies. Neurology 1997; 48:126-132.
63. Taylor TD, Litt M, Kramer P, et al. Homozygosity mapping of Hallervorden-Spatz syndrome to chromosome 20p12.3-p13. Nat Genet 1996; 14:479-481.
64. Valente EM, Bentivoglio AR, Dixon PH, et al. Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36. Am J Hum Genet 2001; 68:895-900.
65. Van Duijn CM, Dekker MCJ, Bonifati V, et al. PARK7, a novel locus for autosomal recessive early-onset parkinsonism on chromosome 1p36. Am J Hum Genet 2001; 69:629-634.
66. Valente EM, Brancati F, Ferraria A, et al. PARK6 is a common cause of familial parkinsonism. Ann Neurol 2002; 51:14-18.
67. Hicks A, Petursson H, Jonsson T, et al. A susceptibility gene for late-onset idiopathic Parkinson's disease successfully mapped. Am J Hum Genet 2001; 69:123-200.
68. Sveinbjornsdottir S, Hicks AA, Jonsson T, et al. Familial aggregation of Parkinson's disease in Iceland. N Engl J Med 2000; 343:1765-1770.
69. Leroy E, Boyer R, Auburger G. The ubiquitin pathway in Parkinson's disease. Nature 1998; 395:451-452.
70. Hutton M, Lendon CL, Rizzu P, et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998; 393:702-705.
71. Shah AB, Chernov I, Zhang HT, et al. Identification and analysis of mutations in the Wilson diseases gene (ATP7B): Population frequencies, genotype-phenotype correlation, and functional analyses. Am J Hum Genet 1997; 61:317-328.
72. Wilhelmsen KC, Weeks DE, Nygaard TG, et al. Genetic mapping of "Lubag" (X-linked dystonia-parkinsonism) in a Filipino kindred to the pericentromeric region of the X chromosome. Ann Neurol 1991; 29:124-131.
73. Schmitt HP, Emser W, Heimes C. Familial occurrence of amyotrophic lateral sclerosis, parkinsonism, and dementia. Ann Neurol 1984; 16:642-648.
74. Rosenberg RN, Nyhan WL, Bay C, Shore P. Autosomal dominant striatonigral degeneration. A clinical, pathologic, and biochemical study of a new genetic disorder. Neurology 1976; 26:703-714.
75. Sutton JP, Pulst SM. Atypical parkinsonism in a family of Portuguese ancestry: Absence of CAG repeat expansion in the MJD1 gene. Neurology 1997; 48:1285-1290.
76. Farrer M, Chan P, Chen R, et al. Lewy bodies and parkinsonism in families with parkin mutations. Ann Neurol 2001;50:293-300.